Method for the diagnosis of thyroid cancer based on epigenetic biomarkers

Summary of the technology

Method for the diagnosis of thyroid cancer based on epigenetic biomarkers CSIC and FINBA have developed a low-cost method with high effectiveness for the diagnosis and prognosis of thyroid cancer that are difficult to resolve during preoperative evaluation. This methodology provides a malignancy score measuring the methylation level of various CpG sites determined by a machine learning-based classification system.

Industrial partners from the health industry are being sought to collaborate through a patent licence
agreement.

An offer for Patent Licensing

CSIC - Consejo Superior de Investigaciones Científicas

A solution that might prevent surgery in up to 60% of the cases

Representative scheme of the diagnostic method Thyroid nodules are commonly seen in clinical practice and ~15 % of them are classified as indeterminate under typical techniques, 65-75% of these being benign after surgery and final histologic evaluation. Thus, an alternative methodology is necessary to improve preoperative diagnostic evaluation.
Researchers from CSIC and FINBA, have studied the correlation between methylation level of various CpG sites and the malignancy of a large group of thyroid nodules, selecting the best predictors provided by machine learning calculations.

The resulting method provides a malignancy score based on a minimum classification system of three CpG sites with an accuracy of 0.91, sensitivity of 0.97 and specificity of 0.88 when they are simultaneously implemented using a cross-validation approach.

Main innovations and advantages

· It is a proven solution for improving preoperative diagnostic evaluation potentially preventing most of the surgeries in difficult-to-diagnose cases.

· The methylation probes have been reduced with a minimal classification system constituted by three · CpG probes. The significant discrimination between benign and malign nodules is obtained using any one of the individual

· CpG sites.

· The method is cost-effective and presents high accuracy, sensitivity and specificity.

Intellectual property status

  • Granted Patent
  • Patent application number :-

Related Keywords

  • Medicine, Human Health
  • Cytology, Cancerology, Oncology
  • Detection and Analysis methods
  • Medical/health

About CSIC - Consejo Superior de Investigaciones Científicas

The Spanish National Research Council (in Spanish 'Consejo Superior de Investigaciones Científicas (CSIC)') is a government agency for basic and applied scientific research.

It is the largest public research organization in Spain, with presence in all the Autonomous Communities through 126 centers and 145 associated units.

CSIC - Consejo Superior de Investigaciones Científicas

Never miss an update from CSIC - Consejo Superior de Investigaciones Científicas

Create your free account to connect with CSIC - Consejo Superior de Investigaciones Científicas and thousands of other innovative organizations and professionals worldwide

CSIC - Consejo Superior de Investigaciones Científicas

Send a request for information
to CSIC - Consejo Superior de Investigaciones Científicas

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support